ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 978

A Genome-Wide Interaction Study with Smoking Suggests New Risk Loci for Two Different Subsets of Rheumatoid Arthritis; Results From Swedish Epidemiological Investigation of Rheumatoid Arthritis Study

Xia Jiang1, Henrik Källberg1, Leonid Padyukov2, Lars Klareskog3 and Lars Alfredsson1, 1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 3Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: anti-citrullinated protein/peptide antibodies (ACPA), genomics, human leukocyte antigens (HLA), rheumatoid arthritis (RA) and tobacco use

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is believed to have a multifactorial etiology, involving both genetic and environmental components, and can be divided into two major subsets according to the presence/absence of anti-citrullinated protein/peptide antibodies (ACPA). Smoking is the most established environmental risk factor. Despite progress from genome-wide association studies (GWAS), identified genetic variants only explain a small proportion of RA occurrence. Hypothetically, gene-environment interaction could add etiologic understanding of the disease. The aim of current study was to investigate gene-environment interaction between smoking and SNPs from an Immunochip, with selected SNPs of interest from an inflammatory point of view, for each of the two major RA subsets.

Methods: Data from Swedish EIRA case-control study was analyzed by means of logistic regression models. Smoking history was collected through questionnaires. Heavy smoking was defined as more than 10 pack-years. Genetic information was obtained from an Immunochip scan. Interaction between smoking intensity and 133648 genetic markers that passed quality control were examined for the two RA subsets (1590 ACPA positive cases, 891 ACPA negative cases; compared with 1856 matched controls). Attributable proportion due to interaction together with 95% confidence interval was evaluated for each smoking-SNP pair.

Results: For ACPA positive RA, 390 SNPs were found to significantly interact with heavy smoking after Bonferroni correction, with a majority located in the HLA region (328 out of 390, 84.10%), all of which displayed high linkage disequilibrium (LD); for ACPA negative RA, 56 SNPs passed threshold for significance, most located outside the HLA region (51 out of 56, 91.07%). After adjusting for HLA-DRB1 shared epitope (SE), 37 SNPs remained significant for ACPA positive RA, with 17 (45.95%) confined to HLA region and the rest spread across 9 other chromosomes; for ACPA negative RA, 19 SNPs stood out, all of them outside the HLA region. Through functional prediction and pathway annotation, 24 candidate genes/regions were identified for ACPA positive RA, several of them (C6orf10, GRB10, HCG9, TAP2, PPT2, HLA-E, SMAD3) together with HLA-DR presented a network of antigen presentation pathways; for ACPA negative RA, 13 genes were demonstrated, 6 of them (GP1BA, AFF3, ICOSLG, NOTCH2, TGS1, LYN) constitute T helper cell differentiation pathways. For ACPA positive RA, besides those SNPs in LD with known susceptibility variant at HLA-DRB1, none of the others have previously been identified.

Conclusion: Our study presents the most explicit picture to date, with regard to the patterns of gene-smoking interaction in ACPA positive/negative RA, suggesting fairly contrasting etiology of the two subsets. Our findings support the, by far, greatest influence from HLA-region on ACPA positive RA; while for ACPA negative RA, more genes outside HLA-region contribute to the etiology. Noticeably, for both RA subsets, new SNPs that are not significant in association analyses stand out in interaction analyses, indicating that genetic factors should be considered together with environmental factors in studies of RA etiology.


Disclosure:

X. Jiang,
None;

H. Källberg,
None;

L. Padyukov,
None;

L. Klareskog,
None;

L. Alfredsson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-genome-wide-interaction-study-with-smoking-suggests-new-risk-loci-for-two-different-subsets-of-rheumatoid-arthritis-results-from-swedish-epidemiological-investigation-of-rheumatoid-arthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology